Frontiers in Oncology Impact Factor

In this post, apart from Frontiers in Oncology Impact Factor, I have tried to compile all the necessary information a research scholar would seek before publishing an article in the journal.

About Frontiers in Oncology Journal

Frontiers in Oncology is a highlights research in carcinogenesis and tumor progression, bridging the gap between basic research and clinical applications to advance diagnosis, personalized therapeutics and management strategies

Impact Factor Logo
4.7

Impact Factor

Journal-Rank
1.291

SJR Rank

H Index logo
102

H-index

Frontiers in Oncology Impact Factor

Impact Factor (IF) or often called journal impact factor (JIF) is an index provided by an analytics company named Clarivate. The impact factor is calculated by dividing the number of times the articles are cited in the last two years by the total number of publications in those two years.

  • Total Citations in 2020 and 2021 = 500
  • Total Number of Publications in 2020 and 2021 = 100
  • Impact Factor of the Journal in 2022 = 500/100 = 5

Frontiers in Oncology Impact Factor (2017-2023)

  • Frontiers in Oncology Impact Factor 2017 – 4.416
  • Frontiers in Oncology Impact Factor 2018 – 4.137
  • Frontiers in Oncology Impact Factor 2019 – 4.848
  • Frontiers in Oncology Impact Factor 2020 – 6.244
  • Frontiers in Oncology Impact Factor 2021 – 5.738
  • Frontiers in Oncology Impact Factor 2022 – 4.7 (updated 29 June 2023)

Frontiers in Oncology Impact Factor 2022

Frontiers in Oncology H-index

The h index is a metric for evaluating the cumulative impact of an author’s scholarly output and performance; measures quantity with quality by comparing publications to citations.

Journal H Index Logo

The h index of Frontiers in Oncology Journal is 102, which means among all the published articles in this journal, 102 of these publications have received at least 102 citations each.

Frontiers in Oncology Journal Metrics

ISSN/ESSIN

2234943X

Country

Switzerland

Publisher

Frontiers Group

Open Access

Yes

Frontiers in Oncology CiteScore

CiteScore (CS) of an academic journal is a measure reflecting the yearly average number of citations to recent articles published in that journal.

Cites / Doc. (3 years)20184.521
Cites / Doc. (3 years)20194.553
Cites / Doc. (3 years)20205.685
Cites / Doc. (3 years)20215.775
Cites / Doc. (2 years)20184.110
Cites / Doc. (2 years)20194.660
Cites / Doc. (2 years)20205.565
Cites / Doc. (2 years)20215.360

Frontiers in Oncology SCImago Rank

The SCImago Journal Rank (SJR) indicator is a measure of the scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where the citations come from.

Year SCImago Journal Rank (SJR)
20181.918
20191.654
20201.834
20211.291

Frontiers in Oncology Editorial Board Members

  • Field Chief Editor | Giuseppe Giaccone

A complete list of Editorial Board members can be found here

Frontiers in Oncology Publication Fee (APC)

JournalA Type ArticlesB Type ArticlesC Type ArticlesD Type Articles
Frontiers in OncologyUS$ 3,225US$ 2,020US$ 490Free

A-Type Articles: Original Research, Systematic Review, Methods, Review, Policy and Practice Reviews, Hypothesis & Theory, Technology and Code

B-Type Articles: Mini Review, Perspective, Brief Research Report

C-Type Articles: Data Report, General Commentary, Opinion

D-Type Articles: Correction, Editorial.

Frontiers in Oncology Review Time

Frontiers in Oncology prioritize rapid publication and uses single-blind peer review

Decision time immediate rejectionWithin 7 days
Duration of first review round Around 1-2 months
Accepted to publishing timeAround 32 days
Total handling time accepted manuscriptsAround 77 days

Frontiers in Oncology Reference Style

Frontiers in Oncology use Vancouver (Numbered)

Vancouver Reference Style

ARTICLE IN A PRINT JOURNAL

Sondheimer N, Lindquist S. Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell (2000) 5:163-72.

ARTICLE IN AN ONLINE JOURNAL

Tahimic CGT, Wang Y, Bikle DD. Anabolic effects of IGF-1 signaling on the skeleton. Front Endocrinol (2013) 4:6. doi: 10.3389/fendo.2013.00006

ARTICLE OR CHAPTER IN A BOOK

Sorenson PW, Caprio JC. “Chemoreception,”. In: Evans DH, editor. The Physiology of Fishes. Boca Raton, FL: CRC Press (1998). p. 375-405.

BOOK

Cowan WM, Jessell TM, Zipursky SL. Molecular and Cellular Approaches to Neural Development. New York: Oxford University Press (1997). 345 p.

ABSTRACT

Christensen S, Oppacher F. An analysis of Koza’s computational effort statistic for genetic programming. In: Foster JA, editor. Genetic Programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3–5; Kinsdale, Ireland. Berlin: Springer (2002). p. 182–91.

WEBSITE

World Health Organization. E. coli (2018). https://www.who.int/news-room/fact-sheets/detail/e-coli [Accessed March 15, 2018].

PATENT

Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee. Flexible Endoscopic Grasping and Cutting Device and Positioning Tool Assembly. United States patent US 20020103498 (2002).

DATA

Perdiguero P, Venturas M, Cervera MT, Gil L, Collada C. Data from: Massive sequencing of Ulms minor’s transcriptome provides new molecular tools for a genus under the constant threat of Dutch elm disease. Dryad Digital Repository. (2015) http://dx.doi.org/10.5061/dryad.ps837

THESES AND DISSERTATIONS

Smith, J. (2008) Post-structuralist discourse relative to phenomological pursuits in the deconstructivist arena. [dissertation/master’s thesis]. [Chicago (IL)]: University of Chicago

PREPRINT

Smith, J. Title of the document. Preprint repository name [Preprint] (2008). Available at: https://persistent-url (Accessed March 15, 2018).

Frontiers in Oncology Reference Style

You can download the Vancouver style here – Frontiers in Oncology Endnote Style and Frontiers in Oncology Zotero Style

Frontiers in Oncology Abbreviation

The ISO 4 standard abbreviation for abstracting, indexing, and referencing purposes of Frontiers in Oncology isFront Oncol

Frontiers in Oncology Acceptance Rate

The acceptance rate of a journal is the ratio of the number of articles submitted to the number of articles published.

The acceptance rate for 2021 was on average 60% across all Frontiers journals and as low as 21% in some journals.

Frontiers in Oncology Indexed in

Science is indexed in Scopus, SCImago, Web of Science, and UGC journal ranking

ugc-logo
Web of Science logo

Read More

Similar Posts